Priority Date: 20.12.13 (CN 201310713428)

PROTEIN AND USE THEREOF IN TREATING MULTIPLE SCLEROSIS

  • Application ID: EP14872967
  • Status: The patent has been granted

Attorney

no operation time available
3 offices
active in Legal Services

Specialization

This EP application has the IPC combination A61, C07, and C12. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 122 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 20.12.2013 - Priority Date (CN 201310713428)
  • 25.06.2015 - Publication A1 (WO2015090223)
  • 26.10.2016 - Publication A1 (EP3085710)
  • 13.02.2019 - Publication B1 (EP3085710)